These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Interaction of atenolol with furosemide and calcium and aluminum salts. Kirch W, Schäfer-Korting M, Axthelm T, Köhler H, Mutschler E. Clin Pharmacol Ther; 1981 Oct; 30(4):429-35. PubMed ID: 7285476 [Abstract] [Full Text] [Related]
3. Atenolol kinetics in renal failure. McAinsh J, Holmes BF, Smith S, Hood D, Warren D. Clin Pharmacol Ther; 1980 Sep; 28(3):302-9. PubMed ID: 7408390 [Abstract] [Full Text] [Related]
4. Pharmacokinetics of atenolol and its clinical consequences in patients with angina pectoris. van der Vijgh WJ, Majid PA, de Feyter PJ, Wardeh R, van der Wall EE. Int J Clin Pharmacol Ther Toxicol; 1980 Sep; 18(9):375-7. PubMed ID: 7005122 [Abstract] [Full Text] [Related]
5. Clinical pharmacologic observations on atenolol, a beta-adrenoceptor blocker. Brown HC, Carruthers SG, Johnston GD, Kelly JG, McAinsh J, McDevitt DG, Shanks RG. Clin Pharmacol Ther; 1976 Nov; 20(5):524-34. PubMed ID: 10125 [Abstract] [Full Text] [Related]
9. Kinetics and absolute bioavailability of atenolol. Mason WD, Winer N, Kochak G, Cohen I, Bell R. Clin Pharmacol Ther; 1979 Apr; 25(4):408-15. PubMed ID: 428185 [Abstract] [Full Text] [Related]
10. Human pharmacokinetic and pharmacodynamic studies on Ro31-1118, a new beta-adrenoceptor antagonist. O'Connor PC, Arnold JM, Brown AN, Francis RJ, Finch MB, Galloway DB, Harron DW, McDevitt DG, Shanks RG. Br J Clin Pharmacol; 1985 Mar; 19(3):319-27. PubMed ID: 2859047 [Abstract] [Full Text] [Related]
11. Bioavailability of atenolol formulations. Mcainsh J, Simpson WT, Holmes BF, Young J, Ellis SH. Biopharm Drug Dispos; 1980 Mar; 1(6):323-32. PubMed ID: 7459427 [Abstract] [Full Text] [Related]
12. The assessment in man of the beta-adrenoceptor blocking activity and cardioselectivity of H-I 42 BS, a long acting beta-adrenoceptor blocking drug. Pringle TH, Deering AH, Scott MG, Harron DW, Shanks RG. Br J Clin Pharmacol; 1987 Apr; 23(4):411-23. PubMed ID: 2883988 [Abstract] [Full Text] [Related]
13. Relationship between blood level of atenolol and pharmacologic effect. Amery A, De Plaen JF, Lijnen P, McAinsh J, Reybrouck T. Clin Pharmacol Ther; 1977 Jun; 21(6):691-9. PubMed ID: 324694 [Abstract] [Full Text] [Related]
14. Bioavailability in man of atenolol and chlorthalidone from a combination formulation. McAinsh J, Bastain W, Young J, Harry JD. Biopharm Drug Dispos; 1981 Jun; 2(2):147-56. PubMed ID: 7248478 [Abstract] [Full Text] [Related]
20. The effect of antacid, metoclopramide, and propantheline on the bioavailability of metoprolol and atenolol. Regårdh CG, Lundborg P, Persson BA. Biopharm Drug Dispos; 1981 Sep; 2(1):79-87. PubMed ID: 7236872 [Abstract] [Full Text] [Related] Page: [Next] [New Search]